117 related articles for article (PubMed ID: 3711481)
1. Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysis.
Eisenberg PR; Sherman L; Rich M; Schwartz D; Schechtman K; Geltman EM; Sobel BE; Jaffe AS
J Am Coll Cardiol; 1986 Jun; 7(6):1255-62. PubMed ID: 3711481
[TBL] [Abstract][Full Text] [Related]
2. Paradoxic elevation of fibrinopeptide A after streptokinase: evidence for continued thrombosis despite intense fibrinolysis.
Eisenberg PR; Sherman LA; Jaffe AS
J Am Coll Cardiol; 1987 Sep; 10(3):527-9. PubMed ID: 3624659
[TBL] [Abstract][Full Text] [Related]
3. Failure of fixed dose intravenous heparin to suppress increases in thrombin activity after coronary thrombolysis with streptokinase.
Galvani M; Abendschein DR; Ferrini D; Ottani F; Rusticali F; Eisenberg PR
J Am Coll Cardiol; 1994 Nov; 24(6):1445-52. PubMed ID: 7930274
[TBL] [Abstract][Full Text] [Related]
4. Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activity.
Owen J; Friedman KD; Grossman BA; Wilkins C; Berke AD; Powers ER
Blood; 1988 Aug; 72(2):616-20. PubMed ID: 3135862
[TBL] [Abstract][Full Text] [Related]
5. Conjunctive administration of intravenous heparin attenuates cross-linked fibrin degradation in patients treated with streptokinase.
Galvani M; Abendschein DR; Ferrini D; Ottani F; Rusticali F; Eisenberg PR
Thromb Haemost; 1996 Sep; 76(3):339-43. PubMed ID: 8883267
[TBL] [Abstract][Full Text] [Related]
6. Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
Granger CB; Becker R; Tracy RP; Califf RM; Topol EJ; Pieper KS; Ross AM; Roth S; Lambrew C; Bovill EG
J Am Coll Cardiol; 1998 Mar; 31(3):497-505. PubMed ID: 9502626
[TBL] [Abstract][Full Text] [Related]
7. [Changes in the plasma levels of fibrinopeptide A in acute myocardial infarction after administration of intravenous streptokinase].
Amoriello A; Piantadosi FR; Piccenna L; Amoriello A; Vacca C; Eliseo V
Cardiologia; 1988 Dec; 33(12):1121-6. PubMed ID: 3255497
[No Abstract] [Full Text] [Related]
8. Intraperitoneal heparin in peritoneal dialysis and its effect on fibrinopeptide A in plasma and dialysate.
Gries E; Paar D; Graben N; Bock KD
Haemostasis; 1989; 19(1):21-5. PubMed ID: 2920976
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of patency after thrombolysis in stenotic coronary arteries requires combined inhibition of thrombin and platelets.
Prager NA; Torr-Brown SR; Sobel BE; Abendschein DR
J Am Coll Cardiol; 1993 Jul; 22(1):296-301. PubMed ID: 8509554
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunoassay of fibrinopeptide A-clinical applications.
Kockum C
Thromb Res; 1976 Feb; 8(2):225-36. PubMed ID: 1251352
[No Abstract] [Full Text] [Related]
11. Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots.
Prager NA; Abendschein DR; McKenzie CR; Eisenberg PR
Circulation; 1995 Aug; 92(4):962-7. PubMed ID: 7641380
[TBL] [Abstract][Full Text] [Related]
12. Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension.
Eisenberg PR; Lucore C; Kaufman L; Sobel BE; Jaffe AS; Rich S
Circulation; 1990 Sep; 82(3):841-7. PubMed ID: 2394005
[TBL] [Abstract][Full Text] [Related]
13. Streptokinase induced defibrination assessed by thrombin time: effects on residual coronary stenosis and left ventricular ejection fraction.
Ranjadayalan K; Stevenson R; Marchant B; Umachandran V; Davies SW; Syndercombe-Court D; Gutteridge CN; Timmis AD
Br Heart J; 1992 Aug; 68(2):171-5. PubMed ID: 1389732
[TBL] [Abstract][Full Text] [Related]
14. Hemorrhage vs rethrombosis after thrombolysis for acute myocardial infarction.
Timmis GC; Mammen EF; Ramos RG; Gordon S; Gangadharan V; Hauser AM; Westveer DC; Stewart JR
Arch Intern Med; 1986 Apr; 146(4):667-72. PubMed ID: 3963947
[TBL] [Abstract][Full Text] [Related]
15. Studies on the functionality of newly synthesized fibrinogen after treatment of acute myocardial infarction with streptokinase, increase in the rate of fibrinopeptide release.
Reganon E; Vila V; Aznar J; Lacueva V; Martinez V; Ruano M
Thromb Haemost; 1993 Dec; 70(6):978-83. PubMed ID: 8165621
[TBL] [Abstract][Full Text] [Related]
16. Guide wire thrombogenicity measured by fibrinopeptide A radioimmunoassay.
Casarella WJ; Wilner GD
AJR Am J Roentgenol; 1977 Mar; 128(3):363-6. PubMed ID: 402829
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen Zurich I: impaired release of fibrinopeptide A.
Hofmann V; Gati WP; Straub PW
Thromb Haemost; 1979 Jun; 41(4):709-13. PubMed ID: 483244
[TBL] [Abstract][Full Text] [Related]
18. Relative efficacy of antithrombin compared with antiplatelet agents in accelerating coronary thrombolysis and preventing early reocclusion.
Haskel EJ; Prager NA; Sobel BE; Abendschein DR
Circulation; 1991 Mar; 83(3):1048-56. PubMed ID: 1900222
[TBL] [Abstract][Full Text] [Related]
19. Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction.
Merlini PA; Bauer KA; Oltrona L; Ardissino D; Spinola A; Cattaneo M; Broccolino M; Mannucci PM; Rosenberg RD
J Am Coll Cardiol; 1995 Jan; 25(1):203-9. PubMed ID: 7798503
[TBL] [Abstract][Full Text] [Related]
20. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline.
Nossel HL; Wasser J; Kaplan KL; LaGamma KS; Yudelman I; Canfield RE
J Clin Invest; 1979 Nov; 64(5):1371-8. PubMed ID: 500818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
